Continuous Innovation lies at the heart of Sigachi’s sustained success over three decades. State-of-the-art R & D facility (approved by Government of India, Ministry of Science & Technology, Department of Science and Industrial Research) and experienced experts keep up the innovative spirit to efficiently meet evolving customer demands and ensure Sigachi remains market leader in excipient ecosystem. The in-house R & D Lab has the best facilities to carry out all necessary trials to develop new molecules from conceptualization to lab and finally to commercial scale. The R & D department regularly carries out final application tests of all our ingredients, as they would be in their final form. This helps ascertain the true nature of the ingredient and ensure quality product to the customers. The team supports the customers via their interactive web portal under Ask an Expert.
HiCel™ Silicified Microcrystalline Cellulose (SMCC) product brochure constitutes of product specifications and results of below insightful comparative studies :
HiCel™ Microcrystalline Cellulose product brochure constitutes of product specifications and results of below insightful comparative studies :
BARETab® PH product brochure constitutes of product specifications and results of below insightful comparative studies :
HiLose™ (Croscarmellose Sodium) product brochure constitutes of product specification and results of below insightful comparative studies :
HiCel™MCG product brochure constitutes of product specifications and results of below insightful comparative studies :
HiCel™ CE15 product brochure constitutes of product specifications and results of below insightful comparative studies:
AceCel® SG 1030 product brochure constitutes of product specifications and results of below insightful studies:
CoatCel® (Alpha Cellulose) product brochure constitutes of product specifications and results of below insightful studies:
PureTalc® (Purified Talc) product brochure constitutes of product specifications and results of below insightful studies:
Stargel® (Sodium Starch Glycolate) product brochure constitutes of product specifications and results of below insightful studies:
Manufacturing and Evaluation of Direct Compressible Diclofenac Sodium 75 mg Tablet With BARETab® PH" pharma application leaflet constitutes of formulation specifications and below results obtained from the studies:
Direct Compressible Tablet Preparation of Health Supplement L-Cystine 550 mg With HiCel SMCC LM 90-nutraceutical application leaflet constitutes of formulation specifications and below results obtained from the studies:
Tableting problems associated with Direct Compression Formulation Tableting of low dose API like Folic Acid with BARETab ® PH” Pharma application white paper constitutes of formulation specifications and below results obtained from the studies :
In DC Tablet Formulation:Preeminence of HiCel™ MCC over Dicalcium Phosphate” Pharma application leaflet constitutes of formulation specifications and below results obtained from the studies: